PHILADELPHIA, March 19, 2020 /PRNewswire/ -- Kehoe Law
Firm, P.C. is investigating breach of fiduciary duty claims on
behalf of shareholders of Adamas Pharmaceuticals, Inc. (NasdaqGM:
ADMS) that presently own the common stock of Adamas
Pharmaceuticals, Inc.
On March 16, 2020, a verified
shareholder derivative complaint was filed in United States District Court seeking to remedy
alleged wrongdoing committed by Adamas Pharmaceuticals' directors
and officers from August 8, 2017
through September 30, 2019.
ADMS investors who currently own shares of Adamas
Pharmaceuticals are encouraged to contact either Michael
Yarnoff, Esq., (215) 792-6676, Ext.
804, myarnoff@kehoelawfirm.com, info@kehoelawfirm.com, or
John Kehoe, Esq, (215) 792-6676,
Ext. 801, jkehoe@kehoelawfirm.com, to discuss the
Adamas Pharmaceuticals investigation or potential
legal claims.
Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary,
plaintiff–side law firm dedicated to protecting investors from
securities fraud, breaches of fiduciary duties, and corporate
misconduct. Combined, the partners at Kehoe Law Firm have
served as Lead Counsel or Co-Lead Counsel in cases that have
recovered more than $10 billion on
behalf of institutional and individual
investors.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/adamas-pharmaceuticals-stock--kehoe-law-firm-pc-investigating-breach-of-fiduciary-duty-claims-on-behalf-of-adms-investors--adms-shareholders-encouraged-to-contact-kehoe-law-firm-pc-301027180.html
SOURCE Kehoe Law Firm, P.C.